Related Experiment Video
Updated: Jan 30, 2026
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Tissue-Specific Chk1 Activation Determines Apoptosis by Regulating the Balance of p53 and p21
Marijn T M van Jaarsveld1, Difan Deng1, Erik A C Wiemer2
1Max Planck Institute for Molecular Genetics, Otto Warburg Laboratory, Ihnestr. 63-73, 14195 Berlin, Germany.
Abstract:
The DNA damage response (DDR) protects cells against genomic instability. Surprisingly, little is known about the differences in DDR across tissues, which may affect cancer evolutionary trajectories and chemotherapy response. Using mathematical modeling and quantitative experiments, we found that the DDR is regulated differently in human breast and lung primary cells. Equal levels of cisplatin-DNA lesions caused stronger Chk1 activation in lung cells, leading to resistance. In contrast, breast cells were more resistant and showed more Chk2 activation in response to doxorubicin. Further analyses indicate that Chk1 activity played a regulatory role in p53 phosphorylation, whereas Chk2 activity was essential for p53 activation and p21 expression. We propose a novel "friction model," in which the balance of p53 and p21 levels contributes to the apoptotic response in different tissues. Our results suggest that modulating the balance of p53 and p21 dynamics could optimize the response to chemotherapy.
Insights
Cellular responses to DNA damage differ between breast and lung tissues, impacting chemotherapy effectiveness. Understanding these differences, particularly the balance of p53 and p21, could improve cancer treatment strategies.
Area of Science:
- Cellular Biology
- Genomics
- Cancer Research
Background:
- The DNA damage response (DDR) is crucial for maintaining genomic stability.
- Tissue-specific variations in DDR mechanisms are poorly understood but may influence cancer progression and treatment outcomes.
Purpose of the Study:
- To investigate and compare the DNA damage response (DDR) in human breast and lung primary cells.
- To elucidate the differential regulation of DDR pathways and their impact on chemotherapy sensitivity.
Main Methods:
- Utilized mathematical modeling and quantitative experimental approaches.
- Assessed cellular responses to DNA-damaging agents like cisplatin and doxorubicin.
- Analyzed the activation of key DDR kinases (Chk1, Chk2) and their role in p53 and p21 signaling.
Main Results:
- Lung cells exhibited stronger Chk1 activation and resistance to cisplatin compared to breast cells.
- Breast cells showed greater resistance to doxorubicin, with increased Chk2 activation.
- Identified distinct roles for Chk1 and Chk2 in regulating p53 phosphorylation, activation, and p21 expression, forming the basis of a novel 'friction model'.
Conclusions:
- Tissue-specific differences in DDR pathways, particularly the interplay of p53 and p21, significantly influence cellular responses to genotoxic stress.
- The proposed 'friction model' highlights the importance of p53 and p21 dynamics in determining apoptotic outcomes.
- Targeting the balance of p53 and p21 signaling pathways presents a potential strategy for optimizing chemotherapy efficacy.
Related Concept Videos
01:23Negative Regulator Molecules
02:04Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
01:18Respiratory Regulation of Acid-Base Balance
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
01:29Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
02:58Balancing Redox Equations
01:30Apoptosis